Yahoo Web Search

  1. Ads
    related to AbbVie Inc
  1. The deal for Allergan will give AbbVie another multibillion-dollar product with a lucrative aesthetics business that does not depend on insurance reimbursement, as well as several medical uses.

  2. AbbVie Inc. ABBV is scheduled to report third-quarter 2019 results on Nov 1, before market opens. In the last reported quarter, AbbVie delivered a positive earnings surprise ...

  3. AbbVie Inc’s ABBV flagship product, Humira, has witnessed declining sales in the past couple of quarters given the launch of biosimilars in international markets, especially Europe ...

  4. Wall Street expects a year-over-year increase in earnings on higher revenues when AbbVie (ABBV) reports results for the quarter ended September 2019. While this widely-known consensus ...

  5. AbbVie Inc. ABBV delivered better-than-expected third-quarter 2019 earnings and revenues. AbbVie reported earnings of $2.33 per share in the third quarter, beating the Zacks ...

  6. AbbVie ABBV is set to report its third quarter results before the opening bell on Friday, November 1. The large cap pharmaceutical company has seen its shares decline over 15% in 2019 ...

  7. AbbVie (ABBV) Q3 Earnings and Revenues Beat Estimates

    Zacks via Yahoo FinanceNov 01 13:05 PM

    AbbVie (ABBV) came out with quarterly earnings of $2.33 per share, beating the Zacks Consensus Estimate of $2.29 per share. This quarterly report represents an earnings surprise of 1.75% ...

  8. Top Ranked Growth Stocks to Buy for November 1st

    Zacks via Yahoo FinanceNov 01 15:00 PM

    Career Education Corporation peg-ratio-ttm | Career Education Corporation Quote AbbVie Inc.

  9. The company said it had notified the U.S. antitrust watchdog of its intention to divest its experimental inflammatory bowel disease therapy, brazikumab, and its treatment for a type of pancreatic ...

  10. Top Ranked Income Stocks to Buy for November 4th

    Zacks via Yahoo FinanceNov 04 15:08 PM

    Here are four stocks with buy rank and strong income characteristics for investors to consider today, November 4th: AbbVie (ABBV): This biopharmaceutical company has witnessed the Zacks ...

  1. Ads
    related to AbbVie Inc